Tumor-host cell interactions in the bone disease of myeloma.
Multiple myeloma is a hematological malignancy that is associated with the development of a destructive osteolytic bone disease, which is a major cause of morbidity for patients with myeloma. Interactions between myeloma cells and cells of the bone marrow microenvironment promote both tumor growth a...
Main Authors: | Fowler, J, Edwards, C, Croucher, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.
by: Fowler, J, et al.
Published: (2011) -
Host Bone Marrow-Derived Stromal Cells Promote Myeloma Initiation and Development of Osteolysis
by: Fowler, J, et al.
Published: (2008) -
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo
by: Lwin, S, et al.
Published: (2017) -
Osteoprotegerin and the development of myeloma bone disease
by: Croucher, P, et al.
Published: (2004) -
Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
by: Shipman, C, et al.
Published: (2002)